Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2005 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
The following term was not found in PubMed: Astariz
Page 1
Fosgonimeton attenuates amyloid-beta toxicity in preclinical models of Alzheimer's disease.
Neurotherapeutics. 2024 Apr 9;21(4):e00350. doi: 10.1016/j.neurot.2024.e00350. Online ahead of print.
Neurotherapeutics. 2024.
PMID: 38599894
Free PMC article.
Fosgonimeton, a Novel Positive Modulator of the HGF/MET System, Promotes Neurotrophic and Procognitive Effects in Models of Dementia.
Johnston JL, Reda SM, Setti SE, Taylor RW, Berthiaume AA, Walker WE, Wu W, Moebius HJ, Church KJ.
Johnston JL, et al.
Neurotherapeutics. 2023 Mar;20(2):431-451. doi: 10.1007/s13311-022-01325-5. Epub 2022 Dec 20.
Neurotherapeutics. 2023.
PMID: 36538176
Free PMC article.
Item in Clipboard
Comparison of the properties of rare variants of alpha1-proteinase inhibitor expressed in COS-1 cells and assessment of their potential as risk factors in human disease.
Ray S, Mickleborough TD, Brown JL.
Ray S, et al.
Biochim Biophys Acta. 2005 Jun 10;1740(3):390-402. doi: 10.1016/j.bbadis.2005.03.010. Epub 2005 Apr 8.
Biochim Biophys Acta. 2005.
PMID: 15949707
Free article.
Item in Clipboard
Cite
Cite